Plasma homocysteine concentrations and depression: A twin study

Area of Science:

• Biochemistry and Psychiatry
• Twin Studies in Clinical Research

Background:

• Homocysteine, an amino acid from methionine metabolism, is vital for energy and neurotransmitter synthesis.
• Elevated homocysteine is linked to depression and cardiovascular disease, though depression study results vary.
• Twin studies help control for confounding factors in clinical research.

Purpose of the Study:

• To investigate the association between plasma homocysteine levels and depression in a twin cohort.
• To clarify the relationship between homocysteine and Major Depressive Disorder (MDD) using twin pairs.

Main Methods:

• Assessed homocysteine concentration in 202 male twins from the Vietnam Era Twin Registry.
• Included twin pairs with and without Major Depressive Disorder (MDD), and pairs differing in Beck Depression Inventory (BDI) scores.
• Measured self-reported depressive symptoms using the Beck Depression Inventory (BDI).

Main Results:

• Average homocysteine concentration was 7.9 μmol/L.
• No significant within-pair differences in homocysteine were found for twins discordant for MDD or BDI scores.
• A significant pair-level correlation existed: higher mean BDI scores correlated with higher mean homocysteine levels (p < .001).

Conclusions:

• Findings do not support a causal role for high homocysteine in depression development.
• The observed association likely stems from familial confounding or shared environmental factors influencing both depression and homocysteine.
• Further research should explore these shared factors in the context of homocysteine and depressive disorders.